Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Takeda at: AE.GBR-IRL@takeda.com.

Contact Takeda

Contact Takeda to discuss Revestive▼(teduglutide) or request more information on SBS-IF.

You can get in touch via the form below or email us at uk.sbs.if@takeda.com. We look forward to hearing from you.

SBS-IF, short bowel syndrome with intestinal failure.

C-APROM/GB/REV/0301 Date of preparation March 2025

National Key Account Manager

Charlie.Reed@takeda.com

Commercial Lead – GI Rare

Richard.Bryant@takeda.com